Screening of conditionally reprogrammed patient-derived carcinoma cells identifies ERCC3-MYC interactions as a target in pancreatic cancer
Beglyarova N.,
Banina E.,
Zhou Y.,
Mukhamadeeva R.,
Andrianov G.,
Bobrov E.,
Lysenko E.,
Skobeleva N.,
Gabitova L.,
Restifo D.,
Pressman M.,
Serebriiskii I.,
Hoffman J.,
Paz K.,
Behrens D.,
Khazak V.,
Jablonski S.,
Golemis E.,
Weiner L.,
Astsaturov I.
Связанные документы (рекомендация CORE)